ArticleRMD open2017

Baseline autoantibodies preferentially impact abatacept efficacy in patients with rheumatoid arthritis who are biologic naïve: 6-month results from a real-world, international, prospective study.

Rieke Alten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.